Hadrian's $1.37B Series D: What an $7.87B Valuation Really Tells LPs

Hadrian, the Los Angeles-based startup that builds AI-guided factories for aerospace and defense parts, raised $1.37 billion in a Series D round announced August 6, 2026, at a $7.87 billion post-money valuation. WCM Investment Management, Washington Harbour Partners, Valor Equity Partners, 137 Ventures, and Baillie Gifford co-led the round. You can read the original coverage from TechCrunch. I want to walk you through what this deal actually means if you hold venture fund exposure with any defense-tech line items, because the math here deserves more scrutiny than the headline gives it.

Let's start with what Hadrian does, because the valuation only makes sense once you understand the bet. Founded in 2021 by Chris Power, Hadrian builds automated machine shops that manufacture precision metal parts for submarines, satellites, and aircraft. The pitch is that AI-run factories can cut the time and cost of producing the parts the Pentagon and its prime contractors need, replacing the artisanal, decades-old machining process that has become a bottleneck in U.S. defense production. That bottleneck is real. The Navy is behind schedule on both Virginia-class and Columbia-class submarines, and the supplier base for precision-machined parts has shrunk for years.

The valuation jump, in hard numbers

Here's the trajectory, and it's worth sitting with the pace of it. Hadrian raised a $90 million Series A in March 2022, a $117 million Series B in December 2023 at roughly a $500 million valuation, and a $260 million Series C in July 2025 led by returning backers Founders Fund and Lux Capital, at an undisclosed valuation reported around $1.6 billion. Thirteen months later, the company is worth $7.87 billion. That's roughly a 5x markup on the implied Series C valuation in about a year, and the company has now raised close to $2 billion in total since inception.

The Series D roster tells you who's underwriting that jump. Alongside the five co-leads, participants reportedly included 1789 Capital, Morgan Stanley Wealth Management, Apollo, T. Rowe Price, CapitalG, Andreessen Horowitz, Altimeter, Construct Capital, and JPMorgan's Strategic Investment Group. That's a mix you don't normally see in a single late-stage venture round: traditional growth-equity shops like Valor and CapitalG sitting next to crossover public-market investors like T. Rowe Price and Baillie Gifford, next to wealth-management channels like Morgan Stanley's, next to a private credit giant in Apollo. When mutual fund managers and wealth-management platforms show up in a private Series D, they're pricing the company as a pre-IPO position, not a traditional venture bet on an unproven product.

Use of proceeds is concrete, which I appreciate, because too many megarounds come with vague "scaling operations" language. Hadrian is putting capital into Factory 4 in Cherokee, near Muscle Shoals, Alabama, a $2.4 billion public-private partnership combining roughly $1.5 billion of Hadrian's own capital with about $900 million in Navy and OBBBA-era federal funding, aimed at producing parts for Virginia- and Columbia-class submarines and creating up to 1,000 jobs. The Navy's own press release on the 2.2-million-square-foot facility confirms that funding split and the submarine-parts mandate directly. The company plans to grow headcount from around 700 to 2,000 within a year, across four factories totaling about 2.85 million square feet in California, Arizona, and Alabama. This is capital-intensive, physical-asset growth, not a software company burning cash on customer acquisition.

What this megaround signals about defense-tech pricing

I've watched a few of these defense-tech valuation cycles now, and this one has a specific texture to it. The pricing isn't built on trailing revenue multiples the way a growth-equity round in enterprise software would be. It's built on trajectory: government contract pipeline, Pentagon relationships, and the assumption that reindustrialization spending keeps climbing. Hadrian isn't disclosing revenue figures publicly with this round, which means investors are pricing nearly $8 billion off of contracted and anticipated government work, not audited top-line growth. That's a bet on policy continuity as much as it's a bet on the company.

And Hadrian isn't alone. Anduril Industries, the drone and autonomous-systems maker, raised $5 billion in May 2026 at a $61 billion valuation, double what it was worth a year earlier. Shield AI, the autonomous-flight software company, raised $2 billion in March 2026 at a $12.7 billion valuation. Saronic, the autonomous-boat maker, more than doubled its valuation to $9.25 billion that same month, up from $4 billion just thirteen months earlier. Defense-tech venture funding topped $14.6 billion in the first five months of 2026 alone, according to Crunchbase data cited by Value Add Pulse's tracking, already exceeding all of 2025's record $9.6 billion in that same national-security funding category. This sector is consolidating capital into a small number of scaled "primes-in-waiting" rather than spreading it across a broad field of startups. If you hold a venture fund with a defense-tech sleeve, check whether that sleeve is actually diversified or whether it's five checks into the same five companies everyone else is chasing.

Put the round in historical context and the pattern gets sharper. Venture-backed defense startups raised a combined record in 2025, and 2026 blew past that record within five months, well before Hadrian's Series D even closed. Government demand signals are real, but they are also politically contingent, and contingent demand is a thinner foundation for a $7.87 billion valuation than recurring commercial revenue would be.

For accredited investors with LP positions in late-stage or crossover venture funds, the read-through matters in a specific way. When public-market crossover investors like T. Rowe Price and Baillie Gifford write checks into private rounds at multi-billion-dollar valuations, they are functionally substituting private exposure for what used to be a public-market decision made after IPO, with full audited financials and public disclosure requirements. You're getting the risk profile of a pre-IPO growth stock without the SEC disclosure regime that comes with being public. CNBC's coverage of the round frames this as evidence the "defense tech spending craze" still has legs. I'd frame it more carefully: it's evidence that capital is willing to underwrite defense manufacturing at software-style multiples, and that's a different risk than it looks like on the surface.

The contrarian case: what if this doesn't IPO cleanly

Here's where I want to push back on the enthusiasm, because somebody has to run the downside case before you commit capital to a fund carrying this kind of exposure.

First, valuation risk. A 5x markup in thirteen months without a corresponding disclosed revenue jump means a lot of this value exists on paper until there's a liquidity event. If Hadrian's next round comes in flat or down, every fund that marked its position at the Series D price takes a write-down, and LPs feel that in their quarterly capital account statements even though nothing about the underlying business changed. Late-stage markups built on trajectory rather than trailing numbers are the most fragile kind, because they unwind fast when sentiment shifts. The Bank for International Settlements' 2026 annual report warns that valuations tied to strategically important technology are elevated relative to historical growth benchmarks and that risk premia have compressed to levels suggesting investor complacency. That warning was written about AI infrastructure, but the same mechanism, pricing scarcity and narrative rather than trailing financials, applies directly to defense-tech megarounds.

Second, concentration risk hiding inside diversification. If your venture manager holds Hadrian, Anduril, Shield AI, and Saronic across different funds, that's not four uncorrelated bets. It's one bet on continued U.S. defense-budget growth and OBBBA-style reindustrialization spending, sliced four ways. A change in defense appropriations, a shift in administration priorities, or a slowdown in submarine and munitions programs would hit all four positions at once. Ask your fund manager directly how much of the portfolio's paper gains sit in companies whose revenue depends on the same government spending line.

Third, and this is the scenario nobody wants to talk about at the term sheet stage, is what happens if Hadrian doesn't IPO cleanly. The company is now valued close to $8 billion with heavy fixed-asset commitments in Alabama tied to a public-private partnership structure. If the IPO window stays shut, or opens at a valuation below $7.87 billion, the crossover investors who bought in at this price face a down-round IPO or an extended hold with no clean exit. Defense contractors also carry a specific flavor of execution risk that consumer or software startups don't: cost overruns on fixed-price government contracts, security clearance and export-control compliance costs, and program cancellation risk if a customer service branch changes its acquisition priorities. None of that shows up in a press release about a funding round.

Several venture-backed tech companies that priced strong private rounds in the last cycle traded well below their last private mark once they hit public markets and analysts could see the actual contract backlog and margin structure behind the story. An IPO forces disclosure that private rounds don't require, and disclosure is where inflated trajectories get tested against real numbers. Hadrian will eventually face that test. The only question is whether it faces it at $7.87 billion, above it, or well below it.

I'd also flag the government-dependency angle plainly. Hadrian's Alabama expansion leans on $900 million in Navy and OBBBA funding alongside its own capital. That's a strength when budgets are generous and a liability when they're not. Defense appropriations move on political cycles, and a change in submarine-program funding or a continuing-resolution standoff in Congress can delay the exact contracts this valuation assumes will materialize on schedule.

What to watch if your fund has defense-tech exposure

If you're an accredited investor with capital in a venture fund that holds Hadrian, Anduril, Shield AI, Saronic, or similar names, here's what I'd put on your checklist before your next capital call or annual meeting:

• Ask for revenue disclosure, not just valuation. A markup means little without knowing whether contracted revenue grew proportionally. Push your GP for actual growth metrics behind the mark, not just the headline multiple.
• Map cross-fund concentration. If you hold multiple venture funds, ask each manager for a full position list and check for overlap in defense-tech names. Five funds holding the same five companies is concentration dressed up as diversification.
• Understand the mark-to-market policy. Ask how your fund values illiquid positions between rounds, and whether it uses the most recent round price or a more conservative internal model. This determines how fast your reported NAV moves if sentiment reverses.
• Track the crossover-investor signal. When public mutual funds and wealth-management platforms pile into a private round, it often means an IPO is being prepped within 12-24 months. That's useful information, but it also means the company needs a clean public listing to validate the price crossover investors just paid.
• Watch the federal budget calendar. Continuing resolutions, appropriations fights, and shifts in Navy or Pentagon procurement priorities are now direct inputs into your portfolio's valuation, whether your fund documents say so or not.
• Ask about follow-on reserve capacity. If a portfolio company needs another round before IPO and the market cools, does your fund have the reserves to participate and avoid dilution, or will your position get diluted by new money at a lower price?

Hadrian's business case is genuinely strong. The Navy has a real submarine-parts bottleneck, and automated machining is a sensible way to attack it. Chris Power has built something concrete: four factories, a Navy-backed expansion, and a plan to nearly triple headcount. None of that is in question. What's in question is whether a $7.87 billion price tag, set by a syndicate that includes mutual funds and wealth platforms typically reserved for public equities, can hold up through an IPO process in a sector where budgets, politics, and contract timing move faster than factory construction. If you have LP exposure to this space, don't just celebrate the markup. Ask your manager to show you the math behind it, and ask what the fund's plan is if the exit window doesn't cooperate on schedule.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.